Quick Answer
SPRUCE BIOSCIENCES, INC. reported Long Term Debt of $0.00 for the year ending 2025.
- SPRUCE BIOSCIENCES, INC. showed a decrease of -100.0% in Long Term Debt from 2024 to 2025.
- This data is from SPRUCE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $2.56 million | Q1 2021: $4.84 million | Q2 2021: $4.86 million | Q3 2021: $4.87 million | Q1 2022: $4.49 million | Q2 2022: $4.08 million | Q3 2022: $3.69 million | Q1 2023: $2.90 million | Q2 2023: $2.51 million | Q3 2023: $2.11 million | Q1 2024: $1.32 million | Q2 2024: $923.0 thousand | Q3 2024: $524.0 thousand | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 7 years of available data (2019 to 2025), SPRUCE BIOSCIENCES, INC.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $124.0 thousand | Fiscal year 2023: $1.72 million | Fiscal year 2022: $3.29 million | Fiscal year 2021: $4.88 million | Fiscal year 2020: $1.92 million | Fiscal year 2019: $3.19 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: